Please login to the form below

Not currently logged in
Email:
Password:

Mediator

This page shows the latest Mediator news and features for those working in and with pharma, biotech and healthcare.

Biogen doses first patient in phase 3 systemic lupus erythematosus study

Biogen doses first patient in phase 3 systemic lupus erythematosus study

This receptor has been previously shown to reduce inflammatory cytokine production from pDCs, including type-I IFN (IFN-I) – inflammatory mediators are believed to play a major role in the pathogenesis

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    of the JAK family of kinases leads to an aberrant production of pro-inflammatory mediators, which are involved in the pathogenesis of rheumatoid arthritis, and inhibition of JAK proteins is an

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    Dysfunction in the regulation of the JAK family of molecules is implicated in the aberrant production of pro-inflammatory mediators that are involved in the pathogenesis of rheumatoid arthritis, and inhibition

  • Case study: From Clinical Trials to Real-World Evidence Case study: From Clinical Trials to Real-World Evidence

    on Product X’s real-world experience and heritage within dermatology and rheumatology, since these diseases share a common inflammatory mediator targeted by Product X.

  • Searching for health Searching for health

    The task of conducting the diverse themes needed for innovation is never easy and, in France, it is made even harder by the lingering echoes from the Mediator scandal.

  • Compulsory evaluation in France Compulsory evaluation in France

    The direction of travel shouldn't come as too much of a surprise, following the PIP breast implant health scare and the subsequent scandal around diabetes drug Mediator (benfluorex).

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....